Source,Target,EdgeWeight,論文ID,論文タイトル,所属1,所属2
3 量子・スピン・トポロジカル・先端物性現象の実証・制御・応用,6 リポソーム・LNP・バイオナノ材料,21,https://doi.org/10.1038/s41565-020-0669-6| https://doi.org/10.1038/s41565-021-00898-0| https://doi.org/10.1038/s41565-020-0732-3| https://doi.org/10.1038/s41565-021-00972-7| https://doi.org/10.1038/s41565-024-01754-7| https://doi.org/10.1038/s41565-024-01774-3| https://doi.org/10.1038/s41565-024-01851-7| https://doi.org/10.1038/s41565-020-00798-9| https://doi.org/10.1038/s41565-021-01001-3| https://doi.org/10.1038/s41565-023-01381-8| https://doi.org/10.1038/s41565-023-01371-w| https://doi.org/10.1038/s41565-024-01783-2| https://doi.org/10.1038/s41565-025-01932-1| https://doi.org/10.1038/s41565-024-01679-1| https://doi.org/10.1038/s41565-024-01656-8| https://doi.org/10.1038/s41565-021-00981-6| https://doi.org/10.1038/s41565-021-00893-5| https://doi.org/10.1038/s41565-025-01922-3| https://doi.org/10.1038/s41565-024-01811-1| https://doi.org/10.1038/s41565-022-01292-0| https://doi.org/10.1038/s41565-022-01141-0,Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing| The current landscape of nucleic acid therapeutics| Immune-mediated approaches against COVID-19| T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy| A translational framework to DELIVER nanomedicines to the clinic| Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications| Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy| Structural and dynamics analysis of intrinsically disordered proteins by high-speed atomic force microscopy| The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines| Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery| Active ingredient vs excipient debate for nanomedicines| Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes| Analysis of multi-drug cancer nanomedicine| Virus-like structures for combination antigen protein mRNA vaccination| Liposozyme for wound healing and inflammation resolution| Nanomedicine hitchhikes on neutrophils to the inflamed lung| Designing cryo-enzymatic reactions in subzero liquid water by lipidic mesophase nanoconfinement| Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma| Synthetic syntrophy for adenine nucleotide cross-feeding between metabolically active nanoreactors| Gene delivery beyond the liver| Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19,,
6 リポソーム・LNP・バイオナノ材料,7 ナノバイオ・医療・生体応用実験・評価,90,https://doi.org/10.1038/s41565-020-0669-6| https://doi.org/10.1038/s41565-021-00931-2| https://doi.org/10.1038/s41565-023-01346-x| https://doi.org/10.1038/s41565-020-00782-3| https://doi.org/10.1038/s41565-019-0626-4| https://doi.org/10.1038/s41565-019-0619-3| https://doi.org/10.1038/s41565-020-00810-2| https://doi.org/10.1038/s41565-019-0600-1| https://doi.org/10.1038/s41565-020-00793-0| https://doi.org/10.1038/s41565-020-0739-9| https://doi.org/10.1038/s41565-020-0752-z| https://doi.org/10.1038/s41565-020-00790-3| https://doi.org/10.1038/s41565-021-00923-2| https://doi.org/10.1038/s41565-021-00950-z| https://doi.org/10.1038/s41565-022-01134-z| https://doi.org/10.1038/s41565-023-01404-4| https://doi.org/10.1038/s41565-021-00972-7| https://doi.org/10.1038/s41565-021-00971-8| https://doi.org/10.1038/s41565-023-01580-3| https://doi.org/10.1038/s41565-021-00928-x| https://doi.org/10.1038/s41565-023-01374-7| https://doi.org/10.1038/s41565-023-01533-w| https://doi.org/10.1038/s41565-023-01553-6| https://doi.org/10.1038/s41565-022-01266-2| https://doi.org/10.1038/s41565-023-01523-y| https://doi.org/10.1038/s41565-023-01585-y| https://doi.org/10.1038/s41565-024-01754-7| https://doi.org/10.1038/s41565-023-01522-z| https://doi.org/10.1038/s41565-023-01453-9| https://doi.org/10.1038/s41565-024-01681-7| https://doi.org/10.1038/s41565-024-01785-0| https://doi.org/10.1038/s41565-024-01680-8| https://doi.org/10.1038/s41565-023-01535-8| https://doi.org/10.1038/s41565-024-01769-0| https://doi.org/10.1038/s41565-024-01683-5| https://doi.org/10.1038/s41565-024-01655-9| https://doi.org/10.1038/s41565-024-01613-5| https://doi.org/10.1038/s41565-024-01722-1| https://doi.org/10.1038/s41565-024-01747-6| https://doi.org/10.1038/s41565-024-01851-7| https://doi.org/10.1038/s41565-025-01857-9| https://doi.org/10.1038/s41565-020-0660-2| https://doi.org/10.1038/s41565-021-00897-1| https://doi.org/10.1038/s41565-021-01032-w| https://doi.org/10.1038/s41565-021-00980-7| https://doi.org/10.1038/s41565-021-01048-2| https://doi.org/10.1038/s41565-022-01245-7| https://doi.org/10.1038/s41565-023-01381-8| https://doi.org/10.1038/s41565-023-01476-2| https://doi.org/10.1038/s41565-023-01514-z| https://doi.org/10.1038/s41565-024-01765-4| https://doi.org/10.1038/s41565-024-01783-2| https://doi.org/10.1038/s41565-024-01757-4| https://doi.org/10.1038/s41565-024-01759-2| https://doi.org/10.1038/s41565-024-01727-w| https://doi.org/10.1038/s41565-025-01867-7| https://doi.org/10.1038/s41565-025-01904-5| https://doi.org/10.1038/s41565-025-01932-1| https://doi.org/10.1038/s41565-025-01924-1| https://doi.org/10.1038/s41565-025-01909-0| https://doi.org/10.1038/s41565-023-01444-w| https://doi.org/10.1038/s41565-024-01679-1| https://doi.org/10.1038/s41565-024-01800-4| https://doi.org/10.1038/s41565-024-01656-8| https://doi.org/10.1038/s41565-025-01918-z| https://doi.org/10.1038/s41565-025-01931-2| https://doi.org/10.1038/s41565-025-01952-x| https://doi.org/10.1038/s41565-021-00981-6| https://doi.org/10.1038/s41565-021-00901-8| https://doi.org/10.1038/s41565-024-01637-x| https://doi.org/10.1038/s41565-025-01871-x| https://doi.org/10.1038/s41565-025-01889-1| https://doi.org/10.1038/s41565-025-01922-3| https://doi.org/10.1038/s41565-025-01958-5| https://doi.org/10.1038/s41565-025-01953-w| https://doi.org/10.1038/s41565-023-01503-2| https://doi.org/10.1038/s41565-022-01089-1| https://doi.org/10.1038/s41565-023-01561-6| https://doi.org/10.1038/s41565-024-01760-9| https://doi.org/10.1038/s41565-024-01811-1| https://doi.org/10.1038/s41565-020-00832-w| https://doi.org/10.1038/s41565-020-0675-8| https://doi.org/10.1038/s41565-023-01373-8| https://doi.org/10.1038/s41565-019-0599-3| https://doi.org/10.1038/s41565-024-01682-6| https://doi.org/10.1038/s41565-024-01796-x| https://doi.org/10.1038/s41565-021-01039-3| https://doi.org/10.1038/s41565-020-0635-3| https://doi.org/10.1038/s41565-024-01748-5| https://doi.org/10.1038/s41565-022-01292-0,Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing| Extracellular vesicles as a next-generation drug delivery platform| Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis| Proton-driven transformable nanovaccine for cancer immunotherapy| Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo| Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis| Inducing immune tolerance with dendritic cell-targeting nanomedicines| Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis| A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells| Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health| Dexamethasone nanomedicines for COVID-19| Eliciting B cell immunity against infectious diseases using nanovaccines| Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19| Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy| Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles| Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines| T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy| Acoustically triggered mechanotherapy using genetically encoded gas vesicles| Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity| Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics| Neutrophil hitchhiking for drug delivery to the bone marrow| A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering| Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity| Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy| Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model| Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent| A translational framework to DELIVER nanomedicines to the clinic| Entry and exit of extracellular vesicles to and from the blood circulation| Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy| Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease| Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes| Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells| Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases| Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing| Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms| Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses| Targeting initial tumour–osteoclast spatiotemporal interaction to prevent bone metastasis| Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells| Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery| Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy| Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy| Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry| Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer| Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion| Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects| Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability| Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy| Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery| Electroactive membrane fusion-liposome for increased electron transfer to enhance radiodynamic therapy| Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins| Acid-degradable lipid nanoparticles enhance the delivery of mRNA| Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes| Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics| Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles| Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy| Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth| An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer| Analysis of multi-drug cancer nanomedicine| A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer| Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers| Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium| Virus-like structures for combination antigen protein mRNA vaccination| Filamentous phages as tumour-targeting immunotherapeutic bionanofibres| Liposozyme for wound healing and inflammation resolution| Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection| Engineering pyroptotic vesicles as personalized cancer vaccines| A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy| Nanomedicine hitchhikes on neutrophils to the inflamed lung| COVID-19 may become nanomedicine’s finest hour yet| Controlling the STING pathway to improve immunotherapy| Long-term blood sugar control with smart insulin crystals| A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25| Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma| Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications| A NICER nanovaccine for cancer immunotherapy| Biohybrid nanoparticles for treating arthritis| Boosting dendritic cell nanovaccines| Oral insulin with reduced hypoglycaemic episodes| Publisher Correction: Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease| Synthetic syntrophy for adenine nucleotide cross-feeding between metabolically active nanoreactors| A relaxin-based nanotherapy for liver fibrosis| Author Correction: Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis| Rerouting nanoparticles to bone marrow via neutrophil hitchhiking| Devouring atherosclerotic plaques| Lipid nanoparticles target haematopoietic stem cells| Author Correction: A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy| Nucleic acid delivery differences across species| Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer| Small structural changes in siloxane-based lipidoids improve tissue-specific mRNA delivery| Gene delivery beyond the liver,,
7 ナノバイオ・医療・生体応用実験・評価,8 バイオ応答・治療効果・送達・安全性,192,https://doi.org/10.1038/s41565-020-0669-6| https://doi.org/10.1038/s41565-021-00931-2| https://doi.org/10.1038/s41565-020-00781-4| https://doi.org/10.1038/s41565-020-00812-0| https://doi.org/10.1038/s41565-020-0751-0| https://doi.org/10.1038/s41565-023-01346-x| https://doi.org/10.1038/s41565-022-01098-0| https://doi.org/10.1038/s41565-020-00782-3| https://doi.org/10.1038/s41565-021-00926-z| https://doi.org/10.1038/s41565-020-00843-7| https://doi.org/10.1038/s41565-019-0626-4| https://doi.org/10.1038/s41565-020-0693-6| https://doi.org/10.1038/s41565-019-0619-3| https://doi.org/10.1038/s41565-020-00810-2| https://doi.org/10.1038/s41565-019-0600-1| https://doi.org/10.1038/s41565-021-00856-w| https://doi.org/10.1038/s41565-020-00793-0| https://doi.org/10.1038/s41565-020-0739-9| https://doi.org/10.1038/s41565-022-01125-0| https://doi.org/10.1038/s41565-020-00803-1| https://doi.org/10.1038/s41565-020-0752-z| https://doi.org/10.1038/s41565-020-00790-3| https://doi.org/10.1038/s41565-021-00982-5| https://doi.org/10.1038/s41565-021-00923-2| https://doi.org/10.1038/s41565-022-01225-x| https://doi.org/10.1038/s41565-021-00950-z| https://doi.org/10.1038/s41565-022-01134-z| https://doi.org/10.1038/s41565-023-01404-4| https://doi.org/10.1038/s41565-021-00972-7| https://doi.org/10.1038/s41565-020-00844-6| https://doi.org/10.1038/s41565-022-01189-y| https://doi.org/10.1038/s41565-024-01618-0| https://doi.org/10.1038/s41565-021-00971-8| https://doi.org/10.1038/s41565-023-01580-3| https://doi.org/10.1038/s41565-021-00928-x| https://doi.org/10.1038/s41565-023-01374-7| https://doi.org/10.1038/s41565-022-01174-5| https://doi.org/10.1038/s41565-022-01137-w| https://doi.org/10.1038/s41565-022-01177-2| https://doi.org/10.1038/s41565-023-01447-7| https://doi.org/10.1038/s41565-023-01533-w| https://doi.org/10.1038/s41565-023-01553-6| https://doi.org/10.1038/s41565-022-01266-2| https://doi.org/10.1038/s41565-023-01523-y| https://doi.org/10.1038/s41565-022-01261-7| https://doi.org/10.1038/s41565-022-01296-w| https://doi.org/10.1038/s41565-023-01498-w| https://doi.org/10.1038/s41565-023-01577-y| https://doi.org/10.1038/s41565-022-01310-1| https://doi.org/10.1038/s41565-023-01585-y| https://doi.org/10.1038/s41565-023-01419-x| https://doi.org/10.1038/s41565-024-01754-7| https://doi.org/10.1038/s41565-023-01522-z| https://doi.org/10.1038/s41565-023-01453-9| https://doi.org/10.1038/s41565-023-01416-0| https://doi.org/10.1038/s41565-023-01392-5| https://doi.org/10.1038/s41565-024-01681-7| https://doi.org/10.1038/s41565-024-01687-1| https://doi.org/10.1038/s41565-023-01394-3| https://doi.org/10.1038/s41565-024-01785-0| https://doi.org/10.1038/s41565-024-01680-8| https://doi.org/10.1038/s41565-023-01572-3| https://doi.org/10.1038/s41565-024-01648-8| https://doi.org/10.1038/s41565-024-01624-2| https://doi.org/10.1038/s41565-024-01784-1| https://doi.org/10.1038/s41565-023-01535-8| https://doi.org/10.1038/s41565-023-01565-2| https://doi.org/10.1038/s41565-024-01769-0| https://doi.org/10.1038/s41565-024-01683-5| https://doi.org/10.1038/s41565-024-01655-9| https://doi.org/10.1038/s41565-024-01613-5| https://doi.org/10.1038/s41565-023-01562-5| https://doi.org/10.1038/s41565-024-01722-1| https://doi.org/10.1038/s41565-024-01758-3| https://doi.org/10.1038/s41565-024-01747-6| https://doi.org/10.1038/s41565-024-01851-7| https://doi.org/10.1038/s41565-025-01857-9| https://doi.org/10.1038/s41565-025-01860-0| https://doi.org/10.1038/s41565-020-00776-1| https://doi.org/10.1038/s41565-020-0660-2| https://doi.org/10.1038/s41565-020-0761-y| https://doi.org/10.1038/s41565-020-00817-9| https://doi.org/10.1038/s41565-020-00836-6| https://doi.org/10.1038/s41565-021-00897-1| https://doi.org/10.1038/s41565-020-0701-x| https://doi.org/10.1038/s41565-021-00952-x| https://doi.org/10.1038/s41565-021-01032-w| https://doi.org/10.1038/s41565-021-00980-7| https://doi.org/10.1038/s41565-021-00961-w| https://doi.org/10.1038/s41565-021-01048-2| https://doi.org/10.1038/s41565-022-01198-x| https://doi.org/10.1038/s41565-022-01245-7| https://doi.org/10.1038/s41565-023-01378-3| https://doi.org/10.1038/s41565-023-01381-8| https://doi.org/10.1038/s41565-023-01496-y| https://doi.org/10.1038/s41565-023-01393-4| https://doi.org/10.1038/s41565-023-01476-2| https://doi.org/10.1038/s41565-023-01514-z| https://doi.org/10.1038/s41565-023-01575-0| https://doi.org/10.1038/s41565-024-01694-2| https://doi.org/10.1038/s41565-024-01809-9| https://doi.org/10.1038/s41565-024-01765-4| https://doi.org/10.1038/s41565-024-01783-2| https://doi.org/10.1038/s41565-024-01798-9| https://doi.org/10.1038/s41565-024-01757-4| https://doi.org/10.1038/s41565-024-01733-y| https://doi.org/10.1038/s41565-024-01764-5| https://doi.org/10.1038/s41565-024-01803-1| https://doi.org/10.1038/s41565-024-01629-x| https://doi.org/10.1038/s41565-024-01725-y| https://doi.org/10.1038/s41565-024-01759-2| https://doi.org/10.1038/s41565-024-01727-w| https://doi.org/10.1038/s41565-024-01826-8| https://doi.org/10.1038/s41565-025-01867-7| https://doi.org/10.1038/s41565-025-01904-5| https://doi.org/10.1038/s41565-025-01878-4| https://doi.org/10.1038/s41565-025-01926-z| https://doi.org/10.1038/s41565-025-01932-1| https://doi.org/10.1038/s41565-025-01924-1| https://doi.org/10.1038/s41565-025-01909-0| https://doi.org/10.1038/s41565-022-01249-3| https://doi.org/10.1038/s41565-022-01260-8| https://doi.org/10.1038/s41565-023-01444-w| https://doi.org/10.1038/s41565-023-01363-w| https://doi.org/10.1038/s41565-023-01502-3| https://doi.org/10.1038/s41565-023-01436-w| https://doi.org/10.1038/s41565-022-01265-3| https://doi.org/10.1038/s41565-023-01584-z| https://doi.org/10.1038/s41565-024-01679-1| https://doi.org/10.1038/s41565-024-01800-4| https://doi.org/10.1038/s41565-020-0639-z| https://doi.org/10.1038/s41565-020-0762-x| https://doi.org/10.1038/s41565-023-01592-z| https://doi.org/10.1038/s41565-024-01656-8| https://doi.org/10.1038/s41565-025-01907-2| https://doi.org/10.1038/s41565-025-01929-w| https://doi.org/10.1038/s41565-025-01931-2| https://doi.org/10.1038/s41565-025-01952-x| https://doi.org/10.1038/s41565-021-00981-6| https://doi.org/10.1038/s41565-024-01678-2| https://doi.org/10.1038/s41565-024-01781-4| https://doi.org/10.1038/s41565-024-01786-z| https://doi.org/10.1038/s41565-021-00901-8| https://doi.org/10.1038/s41565-024-01637-x| https://doi.org/10.1038/s41565-024-01644-y| https://doi.org/10.1038/s41565-024-01668-4| https://doi.org/10.1038/s41565-021-00996-z| https://doi.org/10.1038/s41565-024-01761-8| https://doi.org/10.1038/s41565-025-01871-x| https://doi.org/10.1038/s41565-025-01889-1| https://doi.org/10.1038/s41565-025-01922-3| https://doi.org/10.1038/s41565-025-01928-x| https://doi.org/10.1038/s41565-025-01958-5| https://doi.org/10.1038/s41565-025-01953-w| https://doi.org/10.1038/s41565-025-01943-y| https://doi.org/10.1038/s41565-023-01420-4| https://doi.org/10.1038/s41565-023-01503-2| https://doi.org/10.1038/s41565-022-01089-1| https://doi.org/10.1038/s41565-023-01561-6| https://doi.org/10.1038/s41565-024-01760-9| https://doi.org/10.1038/s41565-024-01811-1| https://doi.org/10.1038/s41565-020-00832-w| https://doi.org/10.1038/s41565-021-01006-y| https://doi.org/10.1038/s41565-020-0675-8| https://doi.org/10.1038/s41565-023-01373-8| https://doi.org/10.1038/s41565-022-01212-2| https://doi.org/10.1038/s41565-019-0599-3| https://doi.org/10.1038/s41565-023-01330-5| https://doi.org/10.1038/s41565-024-01797-w| https://doi.org/10.1038/s41565-024-01639-9| https://doi.org/10.1038/s41565-024-01682-6| https://doi.org/10.1038/s41565-024-01701-6| https://doi.org/10.1038/s41565-024-01778-z| https://doi.org/10.1038/s41565-024-01796-x| https://doi.org/10.1038/s41565-021-00864-w| https://doi.org/10.1038/s41565-022-01244-8| https://doi.org/10.1038/s41565-023-01499-9| https://doi.org/10.1038/s41565-023-01568-z| https://doi.org/10.1038/s41565-021-01039-3| https://doi.org/10.1038/s41565-022-01188-z| https://doi.org/10.1038/s41565-020-00842-8| https://doi.org/10.1038/s41565-020-0635-3| https://doi.org/10.1038/s41565-023-01345-y| https://doi.org/10.1038/s41565-023-01531-y| https://doi.org/10.1038/s41565-020-0711-8| https://doi.org/10.1038/s41565-024-01748-5| https://doi.org/10.1038/s41565-024-01810-2| https://doi.org/10.1038/s41565-020-0748-8| https://doi.org/10.1038/s41565-022-01292-0| https://doi.org/10.1038/s41565-023-01437-9| https://doi.org/10.1038/s41565-022-01176-3| https://doi.org/10.1038/s41565-022-01250-w,"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing| Extracellular vesicles as a next-generation drug delivery platform| A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy| Silica nanoparticles enhance disease resistance in Arabidopsis plants| Nanotechnology-based disinfectants and sensors for SARS-CoV-2| Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis| A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy| Proton-driven transformable nanovaccine for cancer immunotherapy| Viscoelastic surface electrode arrays to interface with viscoelastic tissues| Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection| Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo| Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions| Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis| Inducing immune tolerance with dendritic cell-targeting nanomedicines| Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis| Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo| A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells| Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health| A pyroptosis nanotuner for cancer therapy| A new strategy using nanoscale zero-valent iron to simultaneously promote remediation and safe crop production in contaminated soil| Dexamethasone nanomedicines for COVID-19| Eliciting B cell immunity against infectious diseases using nanovaccines| Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety| Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19| Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration| Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy| Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles| Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines| T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy| Photoacoustic molecular imaging-escorted adipose photodynamic–browning synergy for fighting obesity with virus-like complexes| Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostar﻿s| Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles| Acoustically triggered mechanotherapy using genetically encoded gas vesicles| Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity| Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics| Neutrophil hitchhiking for drug delivery to the bone marrow| Nanotechnology-based strategies against SARS-CoV-2 variants| NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis| A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination| Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles| A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering| Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity| Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy| Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model| Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics| A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion| Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours| Urease-powered nanobots for radionuclide bladder cancer therapy| Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma| Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent| Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain| A translational framework to DELIVER nanomedicines to the clinic| Entry and exit of extracellular vesicles to and from the blood circulation| Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy| Controlled delivery of a neurotransmitter–agonist conjugate for functional recovery after severe spinal cord injury| Nano-enabled strategies to enhance biological nitrogen fixation| Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease| Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment| Hierarchical helical carbon nanotube fibre as a bone-integrating anterior cruciate ligament replacement| Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes| Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells| First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses| Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections| Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways| A cuproptosis nanocapsule for cancer radiotherapy| Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases| Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia| Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing| Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms| Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses| Targeting initial tumour–osteoclast spatiotemporal interaction to prevent bone metastasis| Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors| Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells| Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade| Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery| Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy| Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy| A bioinspired polymeric membrane-enclosed insulin crystal achieves long-term, self-regulated drug release for type 1 diabetes therapy| Advanced material modulation of nutritional and phytohormone status alleviates damage from soybean sudden death syndrome| Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry| Functional and morphological adaptation in DNA protocells via signal processing prompted by artificial metalloenzymes| Considerations for designing preclinical cancer immune nanomedicine studies| Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis| Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer| In situ electrochemical generation of nitric oxide for neuronal modulation| Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase| Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion| Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects| Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application| Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability| Carbon nanotube uptake in cyanobacteria for near-infrared imaging and enhanced bioelectricity generation in living photovoltaics| Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy| Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours| Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery| Wireless electrical–molecular quantum signalling for cancer cell apoptosis| An ancestral molecular response to nanomaterial particulates| Electroactive membrane fusion-liposome for increased electron transfer to enhance radiodynamic therapy| Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins| Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres| In vivo magnetogenetics for cell-type-specific targeting and modulation of brain circuits| A cascade X-ray energy converting approach toward radio-afterglow cancer theranostics| Acid-degradable lipid nanoparticles enhance the delivery of mRNA| Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes| Magnetoelectric nanodiscs enable wireless transgene-free neuromodulation| Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics| An artificial metabzyme for tumour-cell-specific metabolic therapy| An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs| Targeted intervention in nerve–cancer crosstalk enhances pancreatic cancer chemotherapy| Genome-wide forward genetic screening to identify receptors and proteins mediating nanoparticle uptake and intracellular processing| Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle| Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles| Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy| Autophagosomes coated in situ with nanodots act as personalized cancer vaccines| Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth| An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer| Gold-modified nanoporous silicon for photoelectrochemical regulation of intracellular condensates| Balancing stealth and targeting to improve nanomedicine efficacy| Analysis of multi-drug cancer nanomedicine| A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer| Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers| Selective targeting of visceral adiposity by polycation nanomedicine| Graphene oxide elicits microbiome-dependent type 2 immune responses via the aryl hydrocarbon receptor| Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium| Carbon nanotube recognition by human Siglec-14 provokes inflammation| Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics| Molecular machines stimulate intercellular calcium waves and cause muscle contraction| Multidrug nanomedicine| Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy| Virus-like structures for combination antigen protein mRNA vaccination| Filamentous phages as tumour-targeting immunotherapeutic bionanofibres| Killing cancer cells by rupturing their lysosomes| When plants and plastic interact| Augmenting insect olfaction performance through nano-neuromodulation| Liposozyme for wound healing and inflammation resolution| Ferumoxytol promotes haematopoietic stem cell post-injury regeneration as a reactive oxygen species scavenger| Electromagnetic wireless remote control of mammalian transgene expression| Engineering pyroptotic vesicles as personalized cancer vaccines| A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy| Nanomedicine hitchhikes on neutrophils to the inflamed lung| Mitochondrial transplantation for ischemic heart disease| Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies| Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium| COVID-19 may become nanomedicine’s finest hour yet| Controlling the STING pathway to improve immunotherapy| Nanoparticles subdue antibiotic-resistant bacteria’s defences while enhancing innate immunity| Nanoparticles for inducing Gaucher disease-like damage in cancer cells| Size-dependent nano–bio interactions| Author Correction: Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways| Long-term blood sugar control with smart insulin crystals| A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25| Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma| Degrading cancer cell mitochondria to improve T cell-mediated killing| Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications| A NICER nanovaccine for cancer immunotherapy| Iron–silver-modified quantum dots act as efficient catalysts in anti-cancer multitherapy through controlled, ultrasound-induced oxidation| Carbon nanotubes activate inflammatory signalling through binding to Siglec-14| Biohybrid nanoparticles for treating arthritis| Boosting dendritic cell nanovaccines| Oral insulin with reduced hypoglycaemic episodes| Publisher Correction: Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease| Synthetic syntrophy for adenine nucleotide cross-feeding between metabolically active nanoreactors| A relaxin-based nanotherapy for liver fibrosis| Cancer cells hijack T-cell mitochondria| Author Correction: Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis| Rerouting nanoparticles to bone marrow via neutrophil hitchhiking| Inheritable nanotubes boost bioimaging and photovoltaics in cyanobacteria| Devouring atherosclerotic plaques| Oligomer nanoparticle release from a biodegradable plastic triggers acute gut inflammation| Author Correction: Graphene oxide electrodes enable electrical stimulation of distinct calcium signalling in brain astrocytes| Acute, controlled inhalation of thin graphene oxide nanosheets in humans with null cardiorespiratory effects| Lipid nanoparticles target haematopoietic stem cells| A magneto-mechanical genetics toolbox for in vivo neuromodulation| Author Correction: Genome-wide forward genetic screening to identify receptors and proteins mediating nanoparticle uptake and intracellular processing| Author Correction: A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy| Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy| Improving treatment of solid cancers by nanoconjugate-mediated immune conversion of tumour cells| Author Correction: Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma| Publisher Correction: Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model| Nucleic acid delivery differences across species| Wireless nanomedicine for brain tumors| Nano-enabled immunomodulation| Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer| Intracerebral fate of engineered nanoparticles| Electrochemical cell in the brain| Small structural changes in siloxane-based lipidoids improve tissue-specific mRNA delivery| Organic radio-afterglow nanoprobes for cancer theranostics| Publisher Correction: Programmable multistage drug delivery to lymph nodes| Gene delivery beyond the liver| Photomechanical molecular machines enable control of cell signalling| Author Correction: Cross-species transcriptomic signatures identify mechanisms related to species sensitivity and common responses to nanomaterials| Targeting and reducing abdominal fat using polycations",,東北大
3 量子・スピン・トポロジカル・先端物性現象の実証・制御・応用,8 メモリ・電子デバイス・半導体素子,7,https://doi.org/10.1038/s41565-020-0655-z| https://doi.org/10.1038/s41565-023-01369-4| https://doi.org/10.1038/s41565-023-01370-x| https://doi.org/10.1038/s41565-024-01677-3| https://doi.org/10.1038/s41565-022-01291-1| https://doi.org/10.1038/s41565-023-01358-7| https://doi.org/10.1038/s41565-023-01511-2,Memory devices and applications for in-memory computing| Time-resolved Coulomb collision of single electrons| Two electrons interacting at a mesoscopic beam splitter| Vacuum levitation and motion control on chip| Achieving nanoscale precision using neuromorphic localization microscopy| Bipolar flash for bifunctional computing operations| A tunable two-dimensional crossbar array comprising 16 quantum dots,,
8 メモリ・電子デバイス・半導体素子,8 デバイス動作・システムレベル評価・応用,9,https://doi.org/10.1038/s41565-020-0655-z| https://doi.org/10.1038/s41565-021-01040-w| https://doi.org/10.1038/s41565-025-01874-8| https://doi.org/10.1038/s41565-020-0756-8| https://doi.org/10.1038/s41565-021-00943-y| https://doi.org/10.1038/s41565-025-01942-z| https://doi.org/10.1038/s41565-025-01987-0| https://doi.org/10.1038/s41565-023-01358-7| https://doi.org/10.1038/s41565-021-00891-7,Memory devices and applications for in-memory computing| Three-dimensional transistor arrays for intra- and inter-cellular recording| Quantum-enabled microwave-to-optical transduction via silicon nanomechanics| Publisher Correction: Memory devices and applications for in-memory computing| Scalable massively parallel computing using continuous-time data representation in nanoscale crossbar array| Shuttling arrives for silicon quantum computers| Quantum could be key for financial security| Bipolar flash for bifunctional computing operations| Memristors get the hues,,
8 デバイス動作・システムレベル評価・応用,1 電気・電子・論理・量子デバイス性能,30,https://doi.org/10.1038/s41565-020-0655-z| https://doi.org/10.1038/s41565-020-0724-3| https://doi.org/10.1038/s41565-021-00903-6| https://doi.org/10.1038/s41565-020-0722-5| https://doi.org/10.1038/s41565-020-0641-5| https://doi.org/10.1038/s41565-022-01153-w| https://doi.org/10.1038/s41565-021-00874-8| https://doi.org/10.1038/s41565-023-01343-0| https://doi.org/10.1038/s41565-022-01095-3| https://doi.org/10.1038/s41565-022-01099-z| https://doi.org/10.1038/s41565-023-01339-w| https://doi.org/10.1038/s41565-024-01658-6| https://doi.org/10.1038/s41565-024-01790-3| https://doi.org/10.1038/s41565-021-01041-9| https://doi.org/10.1038/s41565-023-01452-w| https://doi.org/10.1038/s41565-023-01515-y| https://doi.org/10.1038/s41565-023-01391-6| https://doi.org/10.1038/s41565-024-01853-5| https://doi.org/10.1038/s41565-021-01040-w| https://doi.org/10.1038/s41565-025-01856-w| https://doi.org/10.1038/s41565-025-01874-8| https://doi.org/10.1038/s41565-021-00932-1| https://doi.org/10.1038/s41565-020-0756-8| https://doi.org/10.1038/s41565-025-01942-z| https://doi.org/10.1038/s41565-025-01973-6| https://doi.org/10.1038/s41565-022-01077-5| https://doi.org/10.1038/s41565-023-01358-7| https://doi.org/10.1038/s41565-024-01700-7| https://doi.org/10.1038/s41565-022-01239-5| https://doi.org/10.1038/s41565-021-00891-7,"Memory devices and applications for in-memory computing| Two-dimensional materials for next-generation computing technologies| Bilayer of polyelectrolyte films for spontaneous power generation in air up to an integrated 1,000 V output| Power-efficient neural network with artificial dendrites| Power generation by reverse electrodialysis in a single-layer nanoporous membrane made from core–rim polycyclic aromatic hydrocarbons| Ultra-low-energy programmable non-volatile silicon photonics based on phase-change materials with graphene heaters| Energy-efficient Mott activation neuron for full-hardware implementation of neural networks| An in-memory computing architecture based on a duplex two-dimensional material structure for in situ machine learning| Phase-change memtransistive synapses for mixed-plasticity neural computations| Light-driven microdrones| An ultrafast bipolar flash memory for self-activated in-memory computing| Phase-separated porous nanocomposite with ultralow percolation threshold for wireless bioelectronics| Linearly programmable two-dimensional halide perovskite memristor arrays for neuromorphic computing| Full-bandwidth electrophysiology of seizures and epileptiform activity enabled by flexible graphene microtransistor depth neural probes| Multilayer spintronic neural networks with radiofrequency connections| An integrated microwave-to-optics interface for scalable quantum computing| Atomically thin optomemristive feedback neurons| Grover’s algorithm in a four-qubit silicon processor above the fault-tolerant threshold| Three-dimensional transistor arrays for intra- and inter-cellular recording| Nanotech powers on-chip intelligence| Quantum-enabled microwave-to-optical transduction via silicon nanomechanics| Ultra-fast non-volatile memory| Publisher Correction: Memory devices and applications for in-memory computing| Shuttling arrives for silicon quantum computers| Event-driven retinomorphic photodiode with bio-plausible temporal dynamics| Reply to: Detectivities of WS2/HfS2 heterojunctions| Bipolar flash for bifunctional computing operations| Topologically protected edge states for neuromorphic computing| Graphene amplifier reaches the quantum limit| Memristors get the hues",,
2 デバイス・機能材料の設計・開発・動作・応用,6 リポソーム・LNP・バイオナノ材料,27,https://doi.org/10.1038/s41565-021-00931-2| https://doi.org/10.1038/s41565-021-01000-4| https://doi.org/10.1038/s41565-019-0626-4| https://doi.org/10.1038/s41565-020-00793-0| https://doi.org/10.1038/s41565-020-0752-z| https://doi.org/10.1038/s41565-023-01374-7| https://doi.org/10.1038/s41565-022-01085-5| https://doi.org/10.1038/s41565-022-01266-2| https://doi.org/10.1038/s41565-023-01523-y| https://doi.org/10.1038/s41565-023-01522-z| https://doi.org/10.1038/s41565-023-01453-9| https://doi.org/10.1038/s41565-023-01401-7| https://doi.org/10.1038/s41565-024-01680-8| https://doi.org/10.1038/s41565-024-01769-0| https://doi.org/10.1038/s41565-024-01683-5| https://doi.org/10.1038/s41565-024-01833-9| https://doi.org/10.1038/s41565-020-00820-0| https://doi.org/10.1038/s41565-021-01008-w| https://doi.org/10.1038/s41565-021-00915-2| https://doi.org/10.1038/s41565-022-01161-w| https://doi.org/10.1038/s41565-025-01918-z| https://doi.org/10.1038/s41565-021-00901-8| https://doi.org/10.1038/s41565-022-01268-0| https://doi.org/10.1038/s41565-025-01889-1| https://doi.org/10.1038/s41565-023-01503-2| https://doi.org/10.1038/s41565-022-01089-1| https://doi.org/10.1038/s41565-024-01682-6,"Extracellular vesicles as a next-generation drug delivery platform| Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells| Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo| A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells| Dexamethasone nanomedicines for COVID-19| Neutrophil hitchhiking for drug delivery to the bone marrow| A transistor-like pH-sensitive nanodetergent for selective cancer therapy| Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy| Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model| Entry and exit of extracellular vesicles to and from the blood circulation| Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy| Cell spheroid creation by transcytotic intercellular gelation| Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells| Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing| Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms| Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles| Nanomedicine and the COVID-19 vaccines| De novo design of a nanopore for single-molecule detection that incorporates a β-hairpin peptide| Foldamer-based ultrapermeable and highly selective artificial water channels that exclude protons| Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif| Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection| COVID-19 may become nanomedicine’s finest hour yet| Non-reciprocal interaction for living matter| A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25| Biohybrid nanoparticles for treating arthritis| Boosting dendritic cell nanovaccines| Lipid nanoparticles target haematopoietic stem cells",,
6 リポソーム・LNP・バイオナノ材料,13 レビュー・総説・動向分析・社会データ,10,https://doi.org/10.1038/s41565-021-00898-0| https://doi.org/10.1038/s41565-020-0732-3| https://doi.org/10.1038/s41565-021-01017-9| https://doi.org/10.1038/s41565-022-01071-x| https://doi.org/10.1038/s41565-021-01001-3| https://doi.org/10.1038/s41565-023-01347-w| https://doi.org/10.1038/s41565-023-01371-w| https://doi.org/10.1038/s41565-021-00946-9| https://doi.org/10.1038/s41565-025-01951-y| https://doi.org/10.1038/s41565-022-01141-0,The current landscape of nucleic acid therapeutics| Immune-mediated approaches against COVID-19| The ancillary effects of nanoparticles and their implications for nanomedicine| Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines| The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines| mRNA therapy at the convergence of genetics and nanomedicine| Active ingredient vs excipient debate for nanomedicines| Reasons for success and lessons learnt from nanoscale vaccines against COVID-19| The benefits and risks of PEGylation in nanomedicine| Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19,,
13 レビュー・総説・動向分析・社会データ,8 バイオ応答・治療効果・送達・安全性,22,https://doi.org/10.1038/s41565-021-00898-0| https://doi.org/10.1038/s41565-020-0737-y| https://doi.org/10.1038/s41565-020-0732-3| https://doi.org/10.1038/s41565-020-00822-y| https://doi.org/10.1038/s41565-021-01017-9| https://doi.org/10.1038/s41565-020-0706-5| https://doi.org/10.1038/s41565-019-0613-9| https://doi.org/10.1038/s41565-022-01071-x| https://doi.org/10.1038/s41565-023-01409-z| https://doi.org/10.1038/s41565-021-01001-3| https://doi.org/10.1038/s41565-020-0654-0| https://doi.org/10.1038/s41565-023-01347-w| https://doi.org/10.1038/s41565-023-01371-w| https://doi.org/10.1038/s41565-021-00946-9| https://doi.org/10.1038/s41565-022-01270-6| https://doi.org/10.1038/s41565-023-01486-0| https://doi.org/10.1038/s41565-025-01925-0| https://doi.org/10.1038/s41565-025-01951-y| https://doi.org/10.1038/s41565-020-0677-6| https://doi.org/10.1038/s41565-021-00995-0| https://doi.org/10.1038/s41565-020-0766-6| https://doi.org/10.1038/s41565-022-01141-0,"The current landscape of nucleic acid therapeutics| COVID-19 vaccine development and a potential nanomaterial path forward| Immune-mediated approaches against COVID-19| Nanomaterials for T-cell cancer immunotherapy| The ancillary effects of nanoparticles and their implications for nanomedicine| Guiding the design space for nanotechnology to advance sustainable crop production| Carbon nanotubes added to the SIN List as a nanomaterial of Very High Concern| Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines| Developing trends in nanomaterials and their environmental implications| The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines| Grouping all carbon nanotubes into a single substance category is scientifically unjustified| mRNA therapy at the convergence of genetics and nanomedicine| Active ingredient vs excipient debate for nanomedicines| Reasons for success and lessons learnt from nanoscale vaccines against COVID-19| The potential impact of nanomedicine on COVID-19-induced thrombosis| The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation| Better the devil you know than the devil you don’t — PEG challenges in nanomedicine| The benefits and risks of PEGylation in nanomedicine| Notes on environmental nanoscience| The rise of nanoagrochemicals| Nano for agriculture, not the opposite| Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19",,
